237 related articles for article (PubMed ID: 27546841)
1. Pancreatic Cancer: A Review.
Yabar CS; Winter JM
Gastroenterol Clin North Am; 2016 Sep; 45(3):429-45. PubMed ID: 27546841
[TBL] [Abstract][Full Text] [Related]
2. Imaging of pancreatic neoplasms.
Balachandran A; Bhosale PR; Charnsangavej C; Tamm EP
Surg Oncol Clin N Am; 2014 Oct; 23(4):751-88. PubMed ID: 25246049
[TBL] [Abstract][Full Text] [Related]
3. A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review.
Fogel EL; Shahda S; Sandrasegaran K; DeWitt J; Easler JJ; Agarwal DM; Eagleson M; Zyromski NJ; House MG; Ellsworth S; El Hajj I; O'Neil BH; Nakeeb A; Sherman S
Am J Gastroenterol; 2017 Apr; 112(4):537-554. PubMed ID: 28139655
[TBL] [Abstract][Full Text] [Related]
4. Brca2 deficiency and Trp53 deregulation in pancreatic cancer: implications for therapeutic targeting.
Yee NS
Cancer Biol Ther; 2011 Jun; 11(11):969-73. PubMed ID: 21610317
[No Abstract] [Full Text] [Related]
5. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer.
Couch FJ; Johnson MR; Rabe K; Boardman L; McWilliams R; de Andrade M; Petersen G
Cancer Res; 2005 Jan; 65(2):383-6. PubMed ID: 15695377
[TBL] [Abstract][Full Text] [Related]
6. Genetics and Biology of Pancreatic Ductal Adenocarcinoma.
Dunne RF; Hezel AF
Hematol Oncol Clin North Am; 2015 Aug; 29(4):595-608. PubMed ID: 26226899
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.
Witkiewicz AK; McMillan EA; Balaji U; Baek G; Lin WC; Mansour J; Mollaee M; Wagner KU; Koduru P; Yopp A; Choti MA; Yeo CJ; McCue P; White MA; Knudsen ES
Nat Commun; 2015 Apr; 6():6744. PubMed ID: 25855536
[TBL] [Abstract][Full Text] [Related]
8. Familial pancreatic cancer: Concept, management and issues.
Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
[TBL] [Abstract][Full Text] [Related]
9. Fanconi anemia gene mutations in young-onset pancreatic cancer.
van der Heijden MS; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 2003 May; 63(10):2585-8. PubMed ID: 12750283
[TBL] [Abstract][Full Text] [Related]
10. Progression of Chronic Pancreatitis to Pancreatic Cancer: Is There a Role of Gene Mutations as a Screening Tool?
Rashid S; Singh N; Gupta S; Rashid S; Nalika N; Sachdev V; Bal CS; Datta Gupta S; Chauhan SS; Saraya A
Pancreas; 2018 Feb; 47(2):227-232. PubMed ID: 29303908
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer: An update on diagnosis and management.
Loveday BPT; Lipton L; Thomson BN
Aust J Gen Pract; 2019 Dec; 48(12):826-831. PubMed ID: 31774983
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options.
Semaan A; Maitra A
Nat Rev Gastroenterol Hepatol; 2018 Feb; 15(2):76-78. PubMed ID: 29317774
[No Abstract] [Full Text] [Related]
13. Mouse Models of Pancreatic Ductal Adenocarcinoma.
Ponz-Sarvise M; Tuveson DA; Yu KH
Hematol Oncol Clin North Am; 2015 Aug; 29(4):609-17. PubMed ID: 26226900
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of pancreatic cancer.
De La Cruz MS; Young AP; Ruffin MT
Am Fam Physician; 2014 Apr; 89(8):626-32. PubMed ID: 24784121
[TBL] [Abstract][Full Text] [Related]
15. Modifiable and non-modifiable risk factors for pancreatic cancer: A review.
Midha S; Chawla S; Garg PK
Cancer Lett; 2016 Oct; 381(1):269-77. PubMed ID: 27461582
[TBL] [Abstract][Full Text] [Related]
16. [An Evaluation of Outcome of Surgical Treatment for Recurrence after Curative Pancreatectomy for Pancreatic Ductal Cancer].
Miyamoto A; Maeda S; Hama N; Haraguchi N; Yamamoto K; Miyake M; Nishikawa K; Omiya H; Miyazaki M; Ikeda M; Hirao M; Takami K; Sekimoto M; Nakamori S
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1454-6. PubMed ID: 26805061
[TBL] [Abstract][Full Text] [Related]
17. Changing the course of pancreatic cancer--Focus on recent translational advances.
Javle M; Golan T; Maitra A
Cancer Treat Rev; 2016 Mar; 44():17-25. PubMed ID: 26924195
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
Shin SH; Kim SC; Hong SM; Kim YH; Song KB; Park KM; Lee YJ
Pancreas; 2013 Mar; 42(2):216-22. PubMed ID: 23344532
[TBL] [Abstract][Full Text] [Related]
19. Familial pancreatic cancer.
Petersen GM
Semin Oncol; 2016 Oct; 43(5):548-553. PubMed ID: 27899186
[TBL] [Abstract][Full Text] [Related]
20. PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma.
Chapin WJ; Reiss KA
Hematol Oncol Clin North Am; 2022 Oct; 36(5):1019-1032. PubMed ID: 36154785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
